Mitochondrial damage by the “pro-oxidant” peroxisomal proliferator clofibrate

This publication has 48 references indexed in Scilit:

• Establishing the Significance and Optimal Intake of Dietary Antioxidants: The Biomarker Concept
  Published by Oxford University Press (OUP) ,1999
• Effect of the Peroxisome Proliferator Ciprofibrate on Lipid Peroxidation and 8-Hydroxydeoxyguanosine Formation in Transgenic Mice with Elevated Hepatic Catalase Activity
  Free Radical Biology & Medicine, 1998
• Evidence against peroxisome proliferation-induced hepatic oxidative damage
  Biochemical Pharmacology, 1997
• The isoprostanes: Unique bioactive products of lipid peroxidation
  Progress in Lipid Research, 1997
• Thyromimetic Action of the Peroxisome Proliferators Clofibrate, Perfluorooctanoic Acid, and Acetylsalicylic Acid Includes Changes in mRNA Levels for Certain Genes Involved in Mitochondrial Biogenesis
  Archives of Biochemistry and Biophysics, 1996
• Effects of hypolipidaemics cetaben and clofibrate on mitochondrial and peroxisomal enzymes of rat liver
  Journal of Pharmacy and Pharmacology, 1994
• Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
  Proceedings of the National Academy of Sciences, 1992
• Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver
  Toxicology Letters, 1992
• Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators
  Carcinogenesis: Integrative Cancer Research, 1987
• Peroxisome proliferation and hepatocarcinogenesis
  Carcinogenesis: Integrative Cancer Research, 1987